Safety & Efficacy Study of ORGN001 (Formerly ALXN1101) in Pediatric Patients With MoCD Type A Currently Treated With rcPMP

Clinical trial NCT02047461 · COMPLETED

Trial details

NCT number: NCT02047461
Sponsor: Origin Biosciences
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Molybdenum Cofactor Deficiency, Type A

Start date: 2014-04-01
Primary completion: 2022-08-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.